Harmonisation achievements in the Quality area include pivotal
milestones such as the conduct of stability studies, defining relevant
thresholds for impurities testing and a more flexible approach to
pharmaceutical quality based on Good Manufacturing Practice (GMP) risk
management.
-
Stability Q1A - Q1F
-
Analytical Validation Q2
-
Impurities Q3A - Q3D
-
Pharmacopoeias Q4 - Q4B
-
Quality of Biotechnological Products Q5A - Q5E
-
Specifications Q6A- Q6B
-
Good Manufacturing Practice Q7
-
Pharmaceutical Development Q8
-
Quality Risk Management Q9
-
Pharmaceutical Quality System Q10
-
Development and Manufacture of Drug Substances Q11
-
Cross-cutting Topics
12:17 PM
Leo Group India
Posted in: 

0 comments:
Post a Comment